SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-118144
Filing Date
2022-04-26
Accepted
2022-04-25 18:41:03
Documents
13
Period of Report
2022-04-25
Items
Item 5.04: Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d203763d8k.htm   iXBRL 8-K 28171
2 EX-99.1 d203763dex991.htm EX-99.1 11442
  Complete submission text file 0001193125-22-118144.txt   165488

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aku-20220425.xsd EX-101.SCH 2495
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aku-20220425_lab.xml EX-101.LAB 18067
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aku-20220425_pre.xml EX-101.PRE 11312
7 EXTRACTED XBRL INSTANCE DOCUMENT d203763d8k_htm.xml XML 3494
Mailing Address 151 BLOOR STREET WEST, SUITE 603 TORONTO A6 M5S 1S4
Business Address 151 BLOOR STREET WEST, SUITE 603 TORONTO A6 M5S 1S4 844-730-0050
AKUMIN INC. (Filer) CIK: 0001776197 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39479 | Film No.: 22851161
SIC: 8071 Services-Medical Laboratories